Literature DB >> 8757034

Mutations of the noncoding region of the connexin32 gene in X-linked dominant Charcot-Marie-Tooth neuropathy.

V V Ionasescu1, C Searby, R Ionasescu, I M Neuhaus, R Werner.   

Abstract

We studied two families with X-linked dominant Charcot-Marie-Tooth neuropathy. The clinical findings included onset around age 14 years, with moderate weakness of feet extensors and palmar and dorsal interossei, areflexia, distal hypesthesia, and slow progressivity. Motor nerve conduction velocities showed slowing (20 to 30 m/sec) and EMGs were normal. Genetic linkage analysis revealed positive lod scores with the markers of the Xq13.1 region in family 2, but was noninformative in family 1. There were no point mutations in the connexin32 gene coding region. Instead, family 1 revealed a T-to-G transversion at position -528 relative to the ATG start codon, whereas family 2 showed a C-to-T transition at position -458. The first mutation is located in the nerve-specific connexin32 promoter just upstream of the transcription start site, the second is located in the 5' untranslated region of the mRNA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757034     DOI: 10.1212/wnl.47.2.541

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

Review 1.  New ways of initiating translation in eukaryotes?

Authors:  M Kozak
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

2.  Functional alterations in gap junction channels formed by mutant forms of connexin 32: evidence for loss of function as a pathogenic mechanism in the X-linked form of Charcot-Marie-Tooth disease.

Authors:  C K Abrams; M M Freidin; V K Verselis; M V Bennett; T A Bargiello
Journal:  Brain Res       Date:  2001-05-04       Impact factor: 3.252

3.  Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease.

Authors:  Gabriela G Loots; Michaela Kneissel; Hansjoerg Keller; Myma Baptist; Jessie Chang; Nicole M Collette; Dmitriy Ovcharenko; Ingrid Plajzer-Frick; Edward M Rubin
Journal:  Genome Res       Date:  2005-06-17       Impact factor: 9.043

Review 4.  Genetic aspects of Charcot-Marie-Tooth disease.

Authors:  C Bell; N Haites
Journal:  Arch Dis Child       Date:  1998-04       Impact factor: 3.791

5.  Connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease show two distinct behaviors: loss of function and altered gating properties.

Authors:  C Ressot; D Gomès; A Dautigny; D Pham-Dinh; R Bruzzone
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

Review 6.  Molecular genetics of X-linked Charcot-Marie-Tooth disease.

Authors:  Kleopas A Kleopa; Steven S Scherer
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 7.  Do cell junction protein mutations cause an airway phenotype in mice or humans?

Authors:  Eugene H Chang; Alejandro A Pezzulo; Joseph Zabner
Journal:  Am J Respir Cell Mol Biol       Date:  2011-02-04       Impact factor: 6.914

8.  Voltage opens unopposed gap junction hemichannels formed by a connexin 32 mutant associated with X-linked Charcot-Marie-Tooth disease.

Authors:  C K Abrams; M V L Bennett; V K Verselis; T A Bargiello
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

9.  A novel hearing-loss-related mutation occurring in the GJB2 basal promoter.

Authors:  T D Matos; H Caria; H Simões-Teixeira; T Aasen; R Nickel; D J Jagger; A O'Neill; D P Kelsell; G Fialho
Journal:  J Med Genet       Date:  2007-07-27       Impact factor: 6.318

10.  Mutation analysis of the nerve specific promoter of the peripheral myelin protein 22 gene in CMT1 disease and HNPP.

Authors:  E Nelis; P De Jonghe; E De Vriendt; P I Patel; J J Martin; C Van Broeckhoven
Journal:  J Med Genet       Date:  1998-07       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.